3 news items
Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference
ALDX
29 May 24
systems, instead of directly inhibiting or activating single protein targets, with the goal of optimizing multiple pathways at once while minimizing
Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development Day
ALDX
25 Apr 24
targets, with the goal of optimizing multiple pathways at once while minimizing toxicity. Our product candidates include RASP (reactive aldehyde
Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024
ALDX
18 Apr 24
or activating single protein targets, with the goal of optimizing multiple pathways at once while minimizing toxicity. Our product candidates include RASP
- Prev
- 1
- Next